Clinical Study of SHR-1701 Plus Chemotherapy as Perioperative Treatment in Subjects With Gastric Cancer

Clinical trial NCT05149807 · TERMINATED

Trial details

NCT number: NCT05149807
Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Status: TERMINATED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Perioperative Treatment in Subjects With Locally Advanced Resectable Gastric Cancer or Gastroesophageal Junction Cancer

Start date: 2022-01-26
Primary completion: 2024-04-03
Enrollment: 81

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.